Related references
Note: Only part of the references are listed.Antigen depot is not required for alum adjuvanticity
Sharon Hutchison et al.
FASEB JOURNAL (2012)
Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses
Randip Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2012)
GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
Hayedeh Behzad et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
Wendell D. Zollinger et al.
VACCINE (2012)
Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens
Antu K. Dey et al.
EXPERT REVIEW OF VACCINES (2011)
Combination adjuvants: the next generation of adjuvants?
George Mutwiri et al.
EXPERT REVIEW OF VACCINES (2011)
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2011)
Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion
Joanne M. Lumsden et al.
INFECTION AND IMMUNITY (2011)
Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
David T. Hickman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cell Type-Specific Proteasomal Processing of HIV-1 Gag-p24 Results in an Altered Epitope Repertoire
Nicholas J. Steers et al.
JOURNAL OF VIROLOGY (2011)
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
Kwaku Poku Asante et al.
LANCET INFECTIOUS DISEASES (2011)
A 2020 vision for vaccines against HIV, tuberculosis and malaria
Rino Rappuoli et al.
NATURE (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study
Fusheng Li et al.
PLOS ONE (2011)
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
Gavin J. Churchyard et al.
PLOS ONE (2011)
Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo
Pernille Nordly et al.
PHARMACEUTICAL RESEARCH (2011)
Patent data mining: A tool for accelerating HIV vaccine innovation
K. Clark et al.
VACCINE (2011)
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A
Gary R. Matyas et al.
VACCINE (2011)
Highly effective generic adjuvant systems for orphan or poverty-related vaccines
Mangala Rao et al.
VACCINE (2011)
Liposome Technology for Industrial Purposes
Andreas Wagner et al.
JOURNAL OF DRUG DELIVERY (2011)
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines
Gary R. Matyas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Strong HIV-Specific CD4+ and CD8+ T-Lymphocyte Proliferative Responses in Healthy Individuals Immunized with an HIV-1 DNA Vaccine and Boosted with Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 Genes
Said Aboud et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
Ryan C. Anderson et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
Matthew Black et al.
EXPERT REVIEW OF VACCINES (2010)
From Banghasomes to liposomes: A memoir of Alec Bangham, 1921-2010
David W. Deamer
FASEB JOURNAL (2010)
Vaccine Adjuvants: Putting Innate Immunity to Work
Robert L. Coffman et al.
IMMUNITY (2010)
Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen
Malou Henriksen-Lacey et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes
Alice O. Kamphorst et al.
JOURNAL OF IMMUNOLOGY (2010)
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
Rhea N. Coler et al.
PLOS ONE (2010)
Liposome-Coupled Antigens Are Internalized by Antigen-Presenting Cells via Pinocytosis and Cross-Presented to CD8+ T Cells
Yuriko Tanaka et al.
PLOS ONE (2010)
Key structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: Chemical synthesis and functional studies
Shoichi Kusumoto et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
Lipopolysaccharide: Biosynthetic pathway and structure modification
Xiaoyuan Wang et al.
PROGRESS IN LIPID RESEARCH (2010)
Vaccine adjuvants: A priority for vaccine research
Ali M. Harandi et al.
VACCINE (2010)
Unmet needs in modern vaccinology Adjuvants to improve the immune response
Geert Leroux-Roels
VACCINE (2010)
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
Gary R. Matyas et al.
AIDS (2009)
The Expression of Endotoxic Activity in the Limulus Test as Compared to Cytokine Production in Immune Cells
Klaus Brandenburg et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Immunology of TLR-independent vaccine adjuvants
Ennio De Gregorio et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Vaccine adjuvants: scientific challenges and strategic initiatives
Ali M. Harandi et al.
EXPERT REVIEW OF VACCINES (2009)
Moving candidate vaccines into development from research: lessons from HIV
Mark Sullivan
IMMUNOLOGY AND CELL BIOLOGY (2009)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Human Immunodeficiency Virus Type 1 Gag p24 Alters the Composition of Immunoproteasomes and Affects Antigen Presentation
Nicholas J. Steers et al.
JOURNAL OF VIROLOGY (2009)
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Fiona A. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+T-cells, memory CD8+T-cells, and pro-inflammatory cytokines
Nicholas J. Steers et al.
VACCINE (2009)
Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41
Douglas S. Watson et al.
VACCINE (2009)
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
C. R. Casella et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane
Zhen-Yu J. Sun et al.
IMMUNITY (2008)
Modulation of immunoproteasome subunits by liposomal lipid
Nicholas J. Steers et al.
VACCINE (2008)
Lipid A and liposomes containing lipid A as antigens and adjuvants
Carl R. Alving et al.
VACCINE (2008)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Pierre Vandepapeliere et al.
VACCINE (2008)
The perfect mix: recent progress in adjuvant research
Bruno Guy
NATURE REVIEWS MICROBIOLOGY (2007)
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Andreas Muhs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling
Amanda L. Gavin et al.
SCIENCE (2006)
Dendritic-cell interactions with HIV: infection and viral dissemination
Li Wu et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A pilot study of the liposomal MUC1 vaccine BLP25 in prostate specific antigen failures after radical prostatectomy
S. A. North et al.
JOURNAL OF UROLOGY (2006)
Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4
Christian R. H. Raetz et al.
JOURNAL OF LIPID RESEARCH (2006)
Immunity in response to particulate antigen-delivery systems
T Storni et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens
KK Peachman et al.
IMMUNOBIOLOGY (2005)
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Fp-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor
J Neidhart et al.
VACCINE (2004)
Functional microtubules are required for antigen processing by macrophages and dendritic cells
KK Peachman et al.
IMMUNOLOGY LETTERS (2004)
The proteasorne and MHC class I antigen processing
PM Kloetzel
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Structure of bacterial lipopolysaccharides
M Caroff et al.
CARBOHYDRATE RESEARCH (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
M Stefani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
The role of the proteasome activator PA28 in MHC class I antigen processing
A Sijts et al.
MOLECULAR IMMUNOLOGY (2002)
Design and selection of vaccine adjuvants: animal models and human trials
CR Alving
VACCINE (2002)
A liposome-based therapeutic vaccine against β-amyloid plaques on the pancreas of transgenic NORBA mice
C Nicolau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The effect of cholesterol in a liposomal Muc1 vaccine
MM Batenjany et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
M Rao et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Share Paper
